Clinical Trial Update: Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated non-invasive vagal nerve stimulation as a treatment for opioid use disorders; the study is completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Substance Use Disorder
• Substance-related Disorder

Snippet

Sponsor: Emory University | Conditions: Substance-Related Disorders, Substance Use Disorders | Phase 3 | Status: COMPLETED | Results posted: 2023-09-13